Medication reference
Succinylcholine
Monograph awaiting updateThis monograph will be updated in the future.
Historical source. Current clinical review is incomplete. This monograph will be updated in the future.
Succinylcholine - Anectine® (opens in a new tab)Original source URL: https://globalrph.com/dilution/succinylcholine/ | Retrieved 2026-11-04
Source dates, location and integrity
This historical article is separate from the reviewed claim cards. Product formulations and source dates may differ.
- Original source URL
- https://globalrph.com/dilution/succinylcholine/ (opens in a new tab)
- Source date
- Not established in the retrieved source
- Retrieved
- 2026-11-04T19:50:48.443200+00:00
- Source location
- div.post-content
- Packaged content SHA-256
- 90aff34d56363dd764cee7dbe0a98d46ee70c9744d44238a55ced2da70956516
- Original response SHA-256
- 248ede09fcf00eb94d93dad33dfcfa689d3b312cf25d83df754e4dfc42d1b400
- Source body SHA-256
- d97d2c1b883046fae5f2c658e4bc6a39cfc28e60dea0c4e800ee8366fadded47
Succinylcholine (Anectine ®) |
| The authors make no claims of the accuracy of the information contained herein; and these suggested doses and/or guidelines are not a substitute for clinical judgment. Neither GlobalRPh Inc. nor any other party involved in the preparation of this document shall be liable for any special, consequential, or exemplary damages resulting in whole or part from any user's use of or reliance upon this material. PLEASE READ THE DISCLAIMER CAREFULLY BEFORE ACCESSING OR USING THIS SITE. BY ACCESSING OR USING THIS SITE, YOU AGREE TO BE BOUND BY THE TERMS AND CONDITIONS SET FORTH IN THE DISCLAIMER. |
Usual Diluents |
| D5W, NS |
Standard Dilutions [Amount of drug] [Infusion volume] [Infusion rate] |
| Normally given slow IV push.
Continuous infusion: |
Stability / Miscellaneous |
| Supplied: 20 and 50 mg/ml-10ml vial. 100 mg/ml-5,10,20ml vial. EXP: 1 DAY (REF). Label: Refrigerate. Depolarizing skeletal muscle blocker. [Onset: (IM): 2-3 minutes (IV):30-60 seconds] Dosing: DOSAGE AND ADMINISTRATION Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration whenever solution and container permit. Solutions which are not clear and colorless should not be used. -------Adults--------- For Long Surgical Procedures Solutions containing from 1 to 2 mg per mL succinylcholine have commonly been used for continuous infusion. The more dilute solution (1 mg per mL) is probably preferable from the standpoint of ease of control of the rate of administration of the drug and, hence, of relaxation. This IV solution containing 1 mg per mL may be administered at a rate of 0.5 mg (0.5 mL) to 10 mg (10 mL) per minute to obtain the required amount of relaxation. The amount required per minute will depend upon the individual response as well as the degree of relaxation required. Avoid overburdening the circulation with a large volume of fluid. It is recommended that neuromuscular function be carefully monitored with a peripheral nerve stimulator when using succinylcholine by infusion in order to avoid overdose, detect development of Phase II block, follow its rate of recovery, and assess the effects of reversing agents. Intermittent IV injections of succinylcholine may also be used to provide muscle relaxation for long procedures. An IV injection of 0.3 to 1.1 mg/kg may be given initially, followed, at appropriate intervals, by further injections of 0.04 to 0.07 mg/kg to maintain the degree of relaxation required. Intramuscular Use Compatibility and Admixtures HOW SUPPLIED Multiple-dose vials of 10 mL, box of 10 vials (NDC 0781-3009-95). Store in refrigerator at 2° to 8°C (36° to 46°F). The multi-dose vials are stable for up to 14 days at room temperature without significant loss of potency. Sandoz January 2005 Source: [package insert] |
Product identifiers and clinical review status
This monograph will be updated in the future. Historical material is available where present in the original sources; full current exact-product and claim-level review remains pending.
Exact formulation, concentration, container, manufacturer, regulatory identifiers, and a reproducible label snapshot have not all been reconciled.
What remains to be completed
- Retrievable exact-product SPL XML with version, revision, retrieval date and reproducible hash
- Clinically reviewed, individually identified statements with two exact source mappings
- Exact formulation, strength, container, manufacturer/labeler, application and NDC reconciliation
- Renal-function methods and dialysis/CRRT modality review where applicable
- Mechanism provenance, clinical source disagreements and full medication-specific safety reconciliation
Supplemental historical fields
Restored-data provenance and review notes
Source release: 2026-08-31. Current clinical review is incomplete. Original uses of current, verified, or normalized describe the historical source. They do not inherit the status of separately reviewed statements. Product formulations and source dates can differ.
Current review annotations for historical renal, dialysis, mechanism, and product fields
Separate renal reference: Open Renal Dosing Master (opens in a new tab)- Renal
- Status
- not_locally_normalized
- Original classification
- no_routine_adjustment_identified
- Entries
- General note
- Preserve the source-specific renal-function basis. An indexed CrCl table is not interchangeable with unindexed CrCl or eGFR. Generic advice to check a method does not identify the equation for a dose row.
- Dialysis
- Status
- no_local_structured_regimen
- Entries
- General note
- Named modality alone does not establish applicability. CRRT subtype, effluent rate, residual renal function, timing and interruptions require review. Historical absence is not evidence that no guidance exists.
- Mechanisms
- Source kind
- first_look
- Local pointer
- /mechanism
- Original level
- drug_specific
- Provenance classification
- historical_drug_specific_uncorroborated
- Label derived verified
- false
- Independently corroborated
- false
- Exact label section
- Not recorded
- Original source note
- Not recorded
- Review status
- historical_unverified
- Note
- Drug-specific wording in the old file is not proof of independent corroboration or an exact label locator. Consult separately published current mechanism claims where present.
- Future update
- Status
- pending_review
- Message
- This monograph will be updated in the future as current exact-product and claim-level review is completed.
- Source unavailable
- false
- Reason
- The historical content is restored; comprehensive contemporary verification remains incomplete.
Historical first look: uses, mechanism, dosing context, and administration
Recovered v5.1 source content; historical, awaiting current review.
- Id
- succinylcholine
Source ID
H51-194238879E6EAC5D03502882 - Generic name
- Succinylcholine
Source ID
H51-1B039882CD742DDAC6EBDBFD - Class
- Neuromuscular blockade
Source ID
H51-E07FC1F2A3C85999CDEDD3DA - Subclass
- Depolarizing neuromuscular blocker
Source ID
H51-CF99272224EF2064C9F77438 - Primary uses
- Rapid-sequence intubation
Source ID
H51-85651027E2BB8DB118928F4C - Short procedures requiring paralysis
Source ID
H51-546A65BC43FFBADB275F30E4
- Rapid-sequence intubation
- Mechanism
- Persistently activates nicotinic receptors, producing depolarization followed by neuromuscular block.
Source ID
H51-FFE06B2FCF1EA9FBCE1E6C91 - Mechanism level
- drug_specific
Source ID
H51-3600AE9A9E96888CEF8B8478 - Basic dosing orientation
- Adult and pediatric bolus | Existing preparation record; use current package insert for indication-specific selection | Weight-based dose | Not normalized in the preparation record | See current package insert and professional guidance | IV infusion; Adult and pediatric | Weight-based intubation dose | Weight-based intubation dose | Patient- and indication-specific | See current package insert | IV push
Source ID
H51-F3FAD83AB1F1C6DF201B2331 - Administration orientation
- Rapid IV bolus; 20 mg/mL commonly; Rapid IV bolus
Source ID
H51-362922D67BD8EBF9449DEEFF - Renal and population orientation
- Separate renal reference: Open Renal Dosing Master (opens in a new tab)No routine renal adjustment is commonly used for many indications, but verify the current label and clinical context.
Source ID
H51-8E22BD7C48D91CFA84674486 - Key safety orientation
- Hyperkalemic cardiac arrest, malignant hyperthermia, bradycardia, prolonged apnea, and rhabdomyolysis.
Source ID
H51-462BEE5D2CFD98E337FC0AD2 - Avoid in patients at risk for receptor upregulation or occult myopathy per current labeling.
Source ID
H51-4DA44EAE6AB9CDB7FD4C084B
- Hyperkalemic cardiac arrest, malignant hyperthermia, bradycardia, prolonged apnea, and rhabdomyolysis.
- Coverage path
- structured_local_snapshot
Source ID
H51-C4AA8EB9AF195CD501092906 - Coverage path label
- Structured GlobalRPh route snapshot
Source ID
H51-C219785D9DDF7AD0B9317523 - Legacy title
- Succinylcholine
Source ID
H51-1E74BB2E9D17196CC1876D65 - Review note
- First-look orientation only. Verify indication, patient population, weight basis, organ function, exact IV product, dose, concentration, compatibility, rate, and current labeling before use.
Source ID
H51-0DFC48E113875F88EB9CD9A4 - Search text
- Succinylcholine Neuromuscular blockade Depolarizing neuromuscular blocker Rapid-sequence intubation Short procedures requiring paralysis Persistently activates nicotinic receptors, producing depolarization followed by neuromuscular block. Adult and pediatric bolus | Existing preparation record; use current package insert for indication-specific selection | Weight-based dose | Not normalized in the preparation record | See current package insert and professional guidance | IV infusion; Adult and pediatric | Weight-based intubation dose | Weight-based intubation dose | Patient- and indication-specific | See current package insert | IV push Rapid IV bolus; 20 mg/mL commonly; Rapid IV bolus No routine renal adjustment is commonly used for many indications, but verify the current label and clinical context. Hyperkalemic cardiac arrest, malignant hyperthermia, bradycardia, prolonged apnea, and rhabdomyolysis. Avoid in patients at risk for receptor upregulation or occult myopathy per current labeling. Structured GlobalRPh route snapshot
Source ID
H51-0E20BF5CF3A31B169E2E70CA - Official search url
- https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Succinylcholine (opens in a new tab)
Source ID
H51-3108753BECC6E2B61F2A9AEB - Official access mode
- search
Source ID
H51-2A5EFE43D3A395161E628786 - Official access url
- https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Succinylcholine (opens in a new tab)
Source ID
H51-73A3C7ED64A8AE43EC9943F0 - Official search query
- Succinylcholine
Source ID
H51-433B029A0BB7FF0120416011 - Official access reason
- A source-backed DailyMed search is available; select and confirm the exact IV product.
Source ID
H51-848D53F95B02A4A233C8C66E
No separate structured rows were bundled for continuous infusion, dialysis, CRRT. Historical article content and source links may cover these topics.
Historical dilution and intermittent infusion preparation
Recovered v5.1 source content; historical, awaiting current review.
| Population | Amount | Reconstitution | Diluent | Final volume | Concentration | Rate | Stability | Notes |
|---|---|---|---|---|---|---|---|---|
Source IDH51-F19D446EA17FB3D534039E5FSource IDH51-E93E1661F2439FEBCED22A4F | Weight-based doseSource IDH51-6B7E3936210497F1C9C5BF1E | No reconstitution for solution products.Source IDH51-CAEDB01FCC7F6A8549864216 | May use undilutedSource IDH51-83513FBAE5215DCA26CB02AC | SyringeSource IDH51-C42E22558492E29E537D6945 | 20 mg/mL commonlySource IDH51-88315CBE09938151BAEC7C33 | Rapid IV bolusSource IDH51-EAD61832C92107479B7DC299 | Use the shorter of current product labeling, validated stability data, and the applicable USP <797> sterility-based BUD ceiling.Source IDH51-D3B7DFAAB085875A12E4E170 | Verify product storage requirements and screen for contraindications.Source IDH51-DB95AE7A1B43B30A2110C638 |
Historical IV-push guidance
Recovered v5.1 source content; historical, awaiting current review.
| Population | Dose scope | Concentration | Rate | Status |
|---|---|---|---|---|
Source IDH51-1C5B738A784CD1559EDA98A9Source IDH51-AD206BBCAC77B89733A1E03D | Weight-based intubation doseSource IDH51-B561273D0BEEFB5F34F2482C | 20 mg/mL commonlySource IDH51-39867AD1ED1AACC2154C8701 | Rapid IV bolusSource IDH51-40CE68855256CA82D8A510A3 | Airway/anesthesia protocol onlySource IDH51-8F2E561B5956BD4FA7AE4EF9 |
Historical indication and population dosing
Recovered tables and source-separated snapshots; full clinical revalidation remains pending.
Existing dose and route snapshots
| Route | Population | Indication | Dose | Interval | Duration | Administration | Source level | Notes |
|---|---|---|---|---|---|---|---|---|
Source IDH51-93164B7D0E0ED3C1311200A7Source IDH51-97E50D9DC6588E485CC0FD50 | Adult and pediatric bolusSource IDH51-E346EBF1DEB936D3C5BA981B | Existing preparation record; use current package insert for indication-specific selectionSource IDH51-7561AC65335B6E7AC613BCBF | Weight-based doseSource IDH51-9B606677E5FD75CB05BE0427 | Not normalized in the preparation recordSource IDH51-52D4482AB22A85BEBB0C5E08 | See current package insert and professional guidanceSource IDH51-23DA4FB1EF69078B64A83E24 | Rapid IV bolusSource IDH51-A9C63DD3119EE957817C1415 | Existing GlobalRPh structured preparation snapshotSource IDH51-95969AC20BB61433A0368275 | Verify product storage requirements and screen for contraindications.Source IDH51-12F88D26CB4D2379891DC244 |
Source IDH51-AEEE3C923BC2FE3E98474DDCSource IDH51-5BC8766EC36D0C48A6929311 | Adult and pediatricSource IDH51-4C157D3C808D43D472F4A0CA | Weight-based intubation doseSource IDH51-9D8FCA1B791BAA72E24C114F | Weight-based intubation doseSource IDH51-F8D41231D6477136708C3CDB | Patient- and indication-specificSource IDH51-48A04C5356F3C096C2207EAF | See current package insertSource IDH51-8896B51E73C37F210E2FB12C | Rapid IV bolusSource IDH51-1FF646F82E02F681C0800400 | Existing GlobalRPh IV push snapshotSource IDH51-9DFA057D9AE12D21F4C533D2 | Airway/anesthesia protocol onlySource IDH51-C5F0F46D95608AD416265A4E |
Historical renal-function guidance
Recovered v5.1 source content; historical, awaiting current review.
Separate renal reference: Open Renal Dosing Master (opens in a new tab)- Classification
- no_routine_adjustment_identified
Source ID
H51-0627C7ABC2BA075C7028F184 - Summary
- No routine renal adjustment is commonly used for many indications, but verify the current label and clinical context.
Source ID
H51-C9CE4CCD9CE11ABEFDC03962 - Method note
- Use the renal function estimate and body-size convention specified by the selected label or institutional protocol. Do not interchange Cockcroft-Gault CrCl, indexed eGFR, and de-indexed eGFR without confirming the dosing source.
Source ID
H51-3DEF8C43F4CDB2189C957C4E
Historical Common IV uses
Recovered v5.1 source content; historical, awaiting current review.
- Rapid-sequence intubation
Source ID
H51-2EFC8B7449E82A815188A3CE - Short procedures requiring paralysis
Source ID
H51-23CA1485D874BF3594B54C18
Historical Warnings and safeguards
Recovered v5.1 source content; historical, awaiting current review.
- Hyperkalemic cardiac arrest, malignant hyperthermia, bradycardia, prolonged apnea, and rhabdomyolysis.
Source ID
H51-DDBA331BE198918558770839 - Avoid in patients at risk for receptor upregulation or occult myopathy per current labeling.
Source ID
H51-EDCF8D696F0FAC7CC48FCF26
Historical Monitoring
Recovered v5.1 source content; historical, awaiting current review.
- Continuous ECG, oxygenation, and ventilation
Source ID
H51-FA2010D8EF75C81268475987 - Temperature and end-tidal CO2
Source ID
H51-DF8D6B39B4C9A7BE46D43450 - Potassium when risk is present
Source ID
H51-1B79B59FB679EA2101C1C27B
Other recovered source fields and original editorial metadata
Original status words such as current, verified, or normalized describe the historical source release. They do not change the clinical review status of this release.
Catalog source fields
Id
succinylcholineSource ID
H51-C73E4E3D93DF61BDC7D79F53Generic name
SuccinylcholineSource ID
H51-415F643275327408400BA6CFBrand names
- Anectine
Source ID
H51-D312E8E917804682C70DB364
Aliases
- suxamethonium
Source ID
H51-9AF7C0B20BC5425C90AB086A
Class
Neuromuscular blockadeSource ID
H51-3A95F0B719BB54A79E042B19Subclass
Depolarizing neuromuscular blockerSource ID
H51-EC492D891D8246E4C9A507CESummary
Rapid-onset paralytic commonly used for intubation; ready-to-use bolus dosing requires screening for hyperkalemia and malignant hyperthermia risk.Source ID
H51-5394F12B07AA3F6243B03136Populations
- Adult
Source ID
H51-12709F5233946B2D4ECC0DE8 - Pediatric with major warnings
Source ID
H51-5071317D350585218A4F7F9E
Evidence tier
Core reference - verify current labelSource ID
H51-4F457732882DF50E161C1C0BHigh alert
trueSource ID
H51-ECD22E4B7A007550861E0B8AHazardous
falseSource ID
H51-153CE14D100076410A4163ABStatus
ActiveSource ID
H51-FA00FD5BA152964E1C214A2FReviewed
2026-08-29Source ID
H51-DF886DA3C4A4C79E73DF4B7BVersion added
1.2Source ID
H51-D099A03038E08B90DC30FB86Sources
| Label | Url | Kind |
|---|---|---|
Source IDH51-BF819643739BD4E72E52D4BASource IDH51-D2682655B6DA9513E3F4730A | https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Succinylcholine (opens in a new tab)Source IDH51-06C4E09B94C07E08CC40221E | PrimarySource IDH51-74EF26BC48BBB7A47F68B36E |
Source IDH51-05BF2DA7EA15E743BA257AA2Source IDH51-D1FF884BBE8E7C26FE06609C | legacy:autoSource IDH51-87CBB3B686FDD08969990CB8 | LegacySource IDH51-FA6FD9A4FDB79B5F41405D2B |
Legacy title
SuccinylcholineSource ID
H51-6403FB208C3B603DCF0D5B90Clinical release verification
- Audit version
- 3.4
Source ID
H51-169EB0D829A68ABF7998AACA - Audited on
- 2026-08-30
Source ID
H51-491E131930682220163BFC88 - Level
- amber
Source ID
H51-82C5EFB0154B0441D63B3C1C - Release gate
- trusted_professional_source_present_exact_label_unconfirmed
Source ID
H51-A863D2187843C11CE830DA18 - Exact current label candidate
- false
Source ID
H51-E398DCE4670044B5CE7D82C3 - Numeric support ratio
- 0
Source ID
H51-637472489DE5B26A8B239A72 - Reference url count
- 1
Source ID
H51-C34E36A67CACA080352028F9 - Broken reference count
- 0
Source ID
H51-EEF019CE4120B0F4126FADF9 - Point of use confirmation required
- true
Source ID
H51-3671A18635B29A66A73832BC - Note
- Do not treat this record as a fully current product-specific monograph until the exact IV formulation and current sources are confirmed.
Source ID
H51-78ECCC17894297663D53CB92 - Dailymed search url
- https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Succinylcholine (opens in a new tab)
Source ID
H51-116CE92738BC4F88B3AD6CEB
Dosing source fields
Id
succinylcholineSource ID
H51-F0A4408C29364DE562417CBBGeneric name
SuccinylcholineSource ID
H51-1C856DA5272AA55C41F6CE95Coverage status
direct_official_label_access_plus_local_snapshotSource ID
H51-8B2773AD9C8A9B17C698BB21Package insert
- Query name
- Succinylcholine
Source ID
H51-6284E9CE05A5A20506A914AE - Product and route must match
- true
Source ID
H51-81C37CFBF460141996F93CFD - Live current label enabled
- false
Source ID
H51-2DD4FB3753E87E373CEE4979 - Source priority
- Reviewed local summary when available, then a verified DailyMed label or product search when available, followed by professional references and institutional policy.
Source ID
H51-5A2F4668D865F93087622E04 - Direct official label access enabled
- true
Source ID
H51-99D767563D6AE24C8EFFDF1F - Outbound server request required
- false
Source ID
H51-CE47B92B3822222EDEDA1854 - Local summary status
- not_bundled
Source ID
H51-F835FC11F330011B9E02BD9E
Clinical review
- Locally normalized
- false
Source ID
H51-679F734AAABC16E38F316B5D - Reviewed
- 2026-08-29
Source ID
H51-E2FDBE145773CEA3E2E66661 - Status
- Direct official package-insert access enabled; indication-specific local normalization pending.
Source ID
H51-727084AF17007C4019518546
Clinical release verification
- Audit version
- 3.4
Source ID
H51-EA32B815C13B70B0A525848C - Audited on
- 2026-08-30
Source ID
H51-040C316A9C6EEDC771BE3626 - Level
- amber
Source ID
H51-29C64E41A4934C891B1D6E05 - Release gate
- trusted_professional_source_present_exact_label_unconfirmed
Source ID
H51-7CF3C3386E82E98A2FD5B1BE - Exact current label candidate
- false
Source ID
H51-357A3DC4A2435911C90D5FAD - Numeric support ratio
- 0
Source ID
H51-E606C657CCD875F637664D1A - Reference url count
- 1
Source ID
H51-51789633A81F7835E91AAEB2 - Broken reference count
- 0
Source ID
H51-F764521823B502861BA08323 - Point of use confirmation required
- true
Source ID
H51-A67F3F2DE1F313269423FDF4 - Note
- Do not treat this record as a fully current product-specific monograph until the exact IV formulation and current sources are confirmed.
Source ID
H51-F0E6EB633BDD329972EE7645 - Dailymed search url
- https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Succinylcholine (opens in a new tab)
Source ID
H51-E27B63E90D44CB1527054471
Historical preparation assessment
Recovered v5.1 source content; historical, awaiting current review.
- Id
- succinylcholine
Source ID
H51-B1E4C27F134629F7FA1C00FC - Name
- Succinylcholine
Source ID
H51-ECD9A6739370240CA3F5EF1C - Brands
- Anectine
Source ID
H51-467C59E1DF24E66AD99CC8E1 - Therapeutic class
- Neuromuscular blockade
Source ID
H51-2F3A34CB96BF5913422D49EC - Review version
- 3.1
Source ID
H51-52E58CF2CACD3A6A17BDE8A9 - Review date
- 2026-08-30
Source ID
H51-032FBE276B273B095AE29E10 - Release status
- structured_record_current_label_not_confirmed
Source ID
H51-F4C362B022243EAF2FEEF47B - Market status
- Status
- no_current_us_iv_spl_confirmed
Source ID
H51-F7BB44B88067427D47215C4D - Basis
- No high-confidence current IV SPL was automatically selected; legacy information is segregated
Source ID
H51-82231CC936CD0ED48F432F2C
- Ten point assessment
- Exact formulation
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-9740FBA7327AFA8573EF28C0 - Reconstitution concentration
- No reconstitution for solution products.
Source ID
H51-572CEFE42BBE2ED45D0E2771 - Maximum or recommended final concentration
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-9A4DF6830FE6C895D6423BD2 - Appropriate standardized containers
- Syringe
Source ID
H51-B6927CAE342DB28E8C9EDEF1 - Adult dosing range
- Weight-based dose Weight-based intubation dose Weight-based intubation dose
Source ID
H51-43733D7C87DDC0A733DE8A6E - Pediatric dosing range
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-A388FEBD7961DB6A8548ED14 - Neonatal dosing range
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-1BB6518ADDD43BA3667476D2 - Infusion time
- Rapid IV bolus
Source ID
H51-7835278149407E1F333852D0 - Fluid restriction alternatives
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-04A5A0274690D51633C29CEA - Current manufacturer labeling
- Match confidence
- unresolved
Source ID
H51-EEB6D628BA108ADA8C16F9B4 - Url
- https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Succinylcholine (opens in a new tab)
Source ID
H51-E481D26C9757E667F99462CA
- Field provenance
- Exact formulation
- Primary
- not_found
Source ID
H51-0467354849B60423FE22A643
- Reconstitution concentration
- Primary
- existing_structured_record
Source ID
H51-D1FCD47837D95EA4E2AF0ED3
- Maximum or recommended final concentration
- Primary
- not_found
Source ID
H51-CF617E16BD5057F85A0ADACB
- Appropriate standardized containers
- Primary
- existing_structured_record
Source ID
H51-E2429A58A3A419CAEA24605E
- Adult dosing range
- Primary
- existing_structured_record
Source ID
H51-13C611749632580181C97976
- Pediatric dosing range
- Primary
- not_found
Source ID
H51-921382B6A1BA5A493F6006FE
- Neonatal dosing range
- Primary
- not_found
Source ID
H51-C23ACC135B9A8A4DCD8C49C9
- Infusion time
- Primary
- existing_structured_record
Source ID
H51-18EEC1C30D3B54FE7AE2F509
- Fluid restriction alternatives
- Primary
- not_found
Source ID
H51-AB8315F54E5080B541D7D0EB
- Current manufacturer labeling
- Primary
- DailyMed search gateway
Source ID
H51-CAF04BD58C4FB3B783100251
- Population applicability
- Adult
- Applicability
- supported_or_source_present
Source ID
H51-5DE97A9A5512044BAE8437EC - Guide generation allowed
- true
Source ID
H51-BC6A3E4212852815A74AABCD
- Pediatric
- Applicability
- supported_or_source_present
Source ID
H51-2B35B2F59BDBAB9540B79B71 - Guide generation allowed
- false
Source ID
H51-AEABE439FB9CD32BF24ADF48
- Neonatal
- Applicability
- not_established
Source ID
H51-6D041A4E382C548781397EC5 - Guide generation allowed
- false
Source ID
H51-9D3FDD729D5D7C1D224390FD
- Route presence
- Structured dilution
- true
Source ID
H51-AF07066C27E0EF79CC6A3525 - Iv push
- true
Source ID
H51-8D4C34DD99D3A66BF240D0BC - Continuous infusion
- false
Source ID
H51-5EA23FE528D5AF5B6D15A49B - Pediatric source
- true
Source ID
H51-643684123F8C9024F7741723 - Neonatal source
- false
Source ID
H51-17A25F3192F8FD56D7AF0B15
- Legacy reference
- Status
- not_available
Source ID
H51-94E2A3AA47AD7B5812510D42
- Label resolution
- Status
- build_environment_network_unavailable
Source ID
H51-58A0CC2A97723A766BE97A00
- Source files
- catalog.json
Source ID
H51-E54626B50C38A1CA6DA93875 - dosing.json
Source ID
H51-6C123085903FB2B947703968 - legacy-map.json
Source ID
H51-4C229D4A6373A47C7718B655 - new-in-v1.2.json
Source ID
H51-247BDE6B123A2F0A32C6BA93
- catalog.json
- Clinical release note
- Preparation instructions are released only at the evidence level shown. Legacy content remains visibly separate. Exact product, NDC, route, current labeling, and institutional policy must be confirmed.
Source ID
H51-4B500F463403487A63D8E614
Historical statement IDs and source locations
These IDs identify recovered source units. They are not evidence-qualified clinical claims.
| Historical ID | Original source location | Status |
|---|---|---|
H51-C73E4E3D93DF61BDC7D79F53 | catalog.json/records/229/id | Historical; current review incomplete |
H51-415F643275327408400BA6CF | catalog.json/records/229/generic_name | Historical; current review incomplete |
H51-D312E8E917804682C70DB364 | catalog.json/records/229/brand_names/0 | Historical; current review incomplete |
H51-9AF7C0B20BC5425C90AB086A | catalog.json/records/229/aliases/0 | Historical; current review incomplete |
H51-3A95F0B719BB54A79E042B19 | catalog.json/records/229/class | Historical; current review incomplete |
H51-EC492D891D8246E4C9A507CE | catalog.json/records/229/subclass | Historical; current review incomplete |
H51-5394F12B07AA3F6243B03136 | catalog.json/records/229/summary | Historical; current review incomplete |
H51-2EFC8B7449E82A815188A3CE | catalog.json/records/229/common_uses/0 | Historical; current review incomplete |
H51-23CA1485D874BF3594B54C18 | catalog.json/records/229/common_uses/1 | Historical; current review incomplete |
H51-F19D446EA17FB3D534039E5F | catalog.json/records/229/preparations/0 | Historical; current review incomplete |
H51-E93E1661F2439FEBCED22A4F | catalog.json/records/229/preparations/0/population | Historical; current review incomplete |
H51-6B7E3936210497F1C9C5BF1E | catalog.json/records/229/preparations/0/amount | Historical; current review incomplete |
H51-CAEDB01FCC7F6A8549864216 | catalog.json/records/229/preparations/0/reconstitution | Historical; current review incomplete |
H51-83513FBAE5215DCA26CB02AC | catalog.json/records/229/preparations/0/diluent | Historical; current review incomplete |
H51-C42E22558492E29E537D6945 | catalog.json/records/229/preparations/0/final_volume | Historical; current review incomplete |
H51-88315CBE09938151BAEC7C33 | catalog.json/records/229/preparations/0/concentration | Historical; current review incomplete |
H51-EAD61832C92107479B7DC299 | catalog.json/records/229/preparations/0/rate | Historical; current review incomplete |
H51-D3B7DFAAB085875A12E4E170 | catalog.json/records/229/preparations/0/stability | Historical; current review incomplete |
H51-DB95AE7A1B43B30A2110C638 | catalog.json/records/229/preparations/0/notes | Historical; current review incomplete |
H51-1C5B738A784CD1559EDA98A9 | catalog.json/records/229/iv_push/0 | Historical; current review incomplete |
H51-AD206BBCAC77B89733A1E03D | catalog.json/records/229/iv_push/0/population | Historical; current review incomplete |
H51-B561273D0BEEFB5F34F2482C | catalog.json/records/229/iv_push/0/dose_scope | Historical; current review incomplete |
H51-39867AD1ED1AACC2154C8701 | catalog.json/records/229/iv_push/0/concentration | Historical; current review incomplete |
H51-40CE68855256CA82D8A510A3 | catalog.json/records/229/iv_push/0/rate | Historical; current review incomplete |
H51-8F2E561B5956BD4FA7AE4EF9 | catalog.json/records/229/iv_push/0/status | Historical; current review incomplete |
H51-0128018E33E0A4745F9A43BB | catalog.json/records/229/iv_push/0/notes | Historical; current review incomplete |
H51-DDBA331BE198918558770839 | catalog.json/records/229/warnings/0 | Historical; current review incomplete |
H51-EDCF8D696F0FAC7CC48FCF26 | catalog.json/records/229/warnings/1 | Historical; current review incomplete |
H51-FA2010D8EF75C81268475987 | catalog.json/records/229/monitoring/0 | Historical; current review incomplete |
H51-DF8D6B39B4C9A7BE46D43450 | catalog.json/records/229/monitoring/1 | Historical; current review incomplete |
H51-1B79B59FB679EA2101C1C27B | catalog.json/records/229/monitoring/2 | Historical; current review incomplete |
H51-12709F5233946B2D4ECC0DE8 | catalog.json/records/229/populations/0 | Historical; current review incomplete |
H51-5071317D350585218A4F7F9E | catalog.json/records/229/populations/1 | Historical; current review incomplete |
H51-4F457732882DF50E161C1C0B | catalog.json/records/229/evidence_tier | Historical; current review incomplete |
H51-ECD22E4B7A007550861E0B8A | catalog.json/records/229/high_alert | Historical; current review incomplete |
H51-153CE14D100076410A4163AB | catalog.json/records/229/hazardous | Historical; current review incomplete |
H51-FA00FD5BA152964E1C214A2F | catalog.json/records/229/status | Historical; current review incomplete |
H51-DF886DA3C4A4C79E73DF4B7B | catalog.json/records/229/reviewed | Historical; current review incomplete |
H51-D099A03038E08B90DC30FB86 | catalog.json/records/229/version_added | Historical; current review incomplete |
H51-BF819643739BD4E72E52D4BA | catalog.json/records/229/sources/0 | Historical; current review incomplete |
H51-D2682655B6DA9513E3F4730A | catalog.json/records/229/sources/0/label | Historical; current review incomplete |
H51-06C4E09B94C07E08CC40221E | catalog.json/records/229/sources/0/url | Historical; current review incomplete |
H51-74EF26BC48BBB7A47F68B36E | catalog.json/records/229/sources/0/kind | Historical; current review incomplete |
H51-05BF2DA7EA15E743BA257AA2 | catalog.json/records/229/sources/1 | Historical; current review incomplete |
H51-D1FF884BBE8E7C26FE06609C | catalog.json/records/229/sources/1/label | Historical; current review incomplete |
H51-87CBB3B686FDD08969990CB8 | catalog.json/records/229/sources/1/url | Historical; current review incomplete |
H51-FA6FD9A4FDB79B5F41405D2B | catalog.json/records/229/sources/1/kind | Historical; current review incomplete |
H51-6403FB208C3B603DCF0D5B90 | catalog.json/records/229/legacy_title | Historical; current review incomplete |
H51-169EB0D829A68ABF7998AACA | catalog.json/records/229/clinical_release_verification/audit_version | Historical; current review incomplete |
H51-491E131930682220163BFC88 | catalog.json/records/229/clinical_release_verification/audited_on | Historical; current review incomplete |
H51-82C5EFB0154B0441D63B3C1C | catalog.json/records/229/clinical_release_verification/level | Historical; current review incomplete |
H51-A863D2187843C11CE830DA18 | catalog.json/records/229/clinical_release_verification/release_gate | Historical; current review incomplete |
H51-E398DCE4670044B5CE7D82C3 | catalog.json/records/229/clinical_release_verification/exact_current_label_candidate | Historical; current review incomplete |
H51-22FBB17E03F7C7FF090371E9 | catalog.json/records/229/clinical_release_verification/selected_setid | Historical; current review incomplete |
H51-0E534D9DC1B64EF0670D0A88 | catalog.json/records/229/clinical_release_verification/selected_label_title | Historical; current review incomplete |
H51-637472489DE5B26A8B239A72 | catalog.json/records/229/clinical_release_verification/numeric_support_ratio | Historical; current review incomplete |
H51-C34E36A67CACA080352028F9 | catalog.json/records/229/clinical_release_verification/reference_url_count | Historical; current review incomplete |
H51-EEF019CE4120B0F4126FADF9 | catalog.json/records/229/clinical_release_verification/broken_reference_count | Historical; current review incomplete |
H51-3671A18635B29A66A73832BC | catalog.json/records/229/clinical_release_verification/point_of_use_confirmation_required | Historical; current review incomplete |
H51-78ECCC17894297663D53CB92 | catalog.json/records/229/clinical_release_verification/note | Historical; current review incomplete |
H51-116CE92738BC4F88B3AD6CEB | catalog.json/records/229/clinical_release_verification/dailymed_search_url | Historical; current review incomplete |
H51-F0A4408C29364DE562417CBB | dosing.json/records/229/id | Historical; current review incomplete |
H51-1C856DA5272AA55C41F6CE95 | dosing.json/records/229/generic_name | Historical; current review incomplete |
H51-8B2773AD9C8A9B17C698BB21 | dosing.json/records/229/coverage_status | Historical; current review incomplete |
H51-6284E9CE05A5A20506A914AE | dosing.json/records/229/package_insert/query_name | Historical; current review incomplete |
H51-E86D5EF878C3972CCF3D0F67 | dosing.json/records/229/package_insert/preferred_setid | Historical; current review incomplete |
H51-81C37CFBF460141996F93CFD | dosing.json/records/229/package_insert/product_and_route_must_match | Historical; current review incomplete |
H51-2DD4FB3753E87E373CEE4979 | dosing.json/records/229/package_insert/live_current_label_enabled | Historical; current review incomplete |
H51-5A2F4668D865F93087622E04 | dosing.json/records/229/package_insert/source_priority | Historical; current review incomplete |
H51-99D767563D6AE24C8EFFDF1F | dosing.json/records/229/package_insert/direct_official_label_access_enabled | Historical; current review incomplete |
H51-CE47B92B3822222EDEDA1854 | dosing.json/records/229/package_insert/outbound_server_request_required | Historical; current review incomplete |
H51-F835FC11F330011B9E02BD9E | dosing.json/records/229/package_insert/local_summary_status | Historical; current review incomplete |
H51-0627C7ABC2BA075C7028F184 | dosing.json/records/229/renal/classification | Historical; current review incomplete |
H51-C9CE4CCD9CE11ABEFDC03962 | dosing.json/records/229/renal/summary | Historical; current review incomplete |
H51-3DEF8C43F4CDB2189C957C4E | dosing.json/records/229/renal/method_note | Historical; current review incomplete |
H51-93164B7D0E0ED3C1311200A7 | dosing.json/records/229/existing_route_snapshots/0 | Historical; current review incomplete |
H51-97E50D9DC6588E485CC0FD50 | dosing.json/records/229/existing_route_snapshots/0/route | Historical; current review incomplete |
H51-E346EBF1DEB936D3C5BA981B | dosing.json/records/229/existing_route_snapshots/0/population | Historical; current review incomplete |
H51-7561AC65335B6E7AC613BCBF | dosing.json/records/229/existing_route_snapshots/0/indication | Historical; current review incomplete |
H51-9B606677E5FD75CB05BE0427 | dosing.json/records/229/existing_route_snapshots/0/dose | Historical; current review incomplete |
H51-52D4482AB22A85BEBB0C5E08 | dosing.json/records/229/existing_route_snapshots/0/interval | Historical; current review incomplete |
H51-23DA4FB1EF69078B64A83E24 | dosing.json/records/229/existing_route_snapshots/0/duration | Historical; current review incomplete |
H51-A9C63DD3119EE957817C1415 | dosing.json/records/229/existing_route_snapshots/0/administration | Historical; current review incomplete |
H51-95969AC20BB61433A0368275 | dosing.json/records/229/existing_route_snapshots/0/source_level | Historical; current review incomplete |
H51-12F88D26CB4D2379891DC244 | dosing.json/records/229/existing_route_snapshots/0/notes | Historical; current review incomplete |
H51-AEEE3C923BC2FE3E98474DDC | dosing.json/records/229/existing_route_snapshots/1 | Historical; current review incomplete |
H51-5BC8766EC36D0C48A6929311 | dosing.json/records/229/existing_route_snapshots/1/route | Historical; current review incomplete |
H51-4C157D3C808D43D472F4A0CA | dosing.json/records/229/existing_route_snapshots/1/population | Historical; current review incomplete |
H51-9D8FCA1B791BAA72E24C114F | dosing.json/records/229/existing_route_snapshots/1/indication | Historical; current review incomplete |
H51-F8D41231D6477136708C3CDB | dosing.json/records/229/existing_route_snapshots/1/dose | Historical; current review incomplete |
H51-48A04C5356F3C096C2207EAF | dosing.json/records/229/existing_route_snapshots/1/interval | Historical; current review incomplete |
H51-8896B51E73C37F210E2FB12C | dosing.json/records/229/existing_route_snapshots/1/duration | Historical; current review incomplete |
H51-1FF646F82E02F681C0800400 | dosing.json/records/229/existing_route_snapshots/1/administration | Historical; current review incomplete |
H51-9DFA057D9AE12D21F4C533D2 | dosing.json/records/229/existing_route_snapshots/1/source_level | Historical; current review incomplete |
H51-C5F0F46D95608AD416265A4E | dosing.json/records/229/existing_route_snapshots/1/notes | Historical; current review incomplete |
H51-679F734AAABC16E38F316B5D | dosing.json/records/229/clinical_review/locally_normalized | Historical; current review incomplete |
H51-E2FDBE145773CEA3E2E66661 | dosing.json/records/229/clinical_review/reviewed | Historical; current review incomplete |
H51-727084AF17007C4019518546 | dosing.json/records/229/clinical_review/status | Historical; current review incomplete |
H51-EA32B815C13B70B0A525848C | dosing.json/records/229/clinical_release_verification/audit_version | Historical; current review incomplete |
H51-040C316A9C6EEDC771BE3626 | dosing.json/records/229/clinical_release_verification/audited_on | Historical; current review incomplete |
H51-29C64E41A4934C891B1D6E05 | dosing.json/records/229/clinical_release_verification/level | Historical; current review incomplete |
H51-7CF3C3386E82E98A2FD5B1BE | dosing.json/records/229/clinical_release_verification/release_gate | Historical; current review incomplete |
H51-357A3DC4A2435911C90D5FAD | dosing.json/records/229/clinical_release_verification/exact_current_label_candidate | Historical; current review incomplete |
H51-1027C90DE4A0E3BC1A7CBD42 | dosing.json/records/229/clinical_release_verification/selected_setid | Historical; current review incomplete |
H51-6392150EA6966DF21E507751 | dosing.json/records/229/clinical_release_verification/selected_label_title | Historical; current review incomplete |
H51-E606C657CCD875F637664D1A | dosing.json/records/229/clinical_release_verification/numeric_support_ratio | Historical; current review incomplete |
H51-51789633A81F7835E91AAEB2 | dosing.json/records/229/clinical_release_verification/reference_url_count | Historical; current review incomplete |
H51-F764521823B502861BA08323 | dosing.json/records/229/clinical_release_verification/broken_reference_count | Historical; current review incomplete |
H51-A67F3F2DE1F313269423FDF4 | dosing.json/records/229/clinical_release_verification/point_of_use_confirmation_required | Historical; current review incomplete |
H51-F0E6EB633BDD329972EE7645 | dosing.json/records/229/clinical_release_verification/note | Historical; current review incomplete |
H51-E27B63E90D44CB1527054471 | dosing.json/records/229/clinical_release_verification/dailymed_search_url | Historical; current review incomplete |
H51-194238879E6EAC5D03502882 | first-look-v5.1.json/records/229/id | Historical; current review incomplete |
H51-1B039882CD742DDAC6EBDBFD | first-look-v5.1.json/records/229/generic_name | Historical; current review incomplete |
H51-E07FC1F2A3C85999CDEDD3DA | first-look-v5.1.json/records/229/class | Historical; current review incomplete |
H51-CF99272224EF2064C9F77438 | first-look-v5.1.json/records/229/subclass | Historical; current review incomplete |
H51-85651027E2BB8DB118928F4C | first-look-v5.1.json/records/229/primary_uses/0 | Historical; current review incomplete |
H51-546A65BC43FFBADB275F30E4 | first-look-v5.1.json/records/229/primary_uses/1 | Historical; current review incomplete |
H51-FFE06B2FCF1EA9FBCE1E6C91 | first-look-v5.1.json/records/229/mechanism | Historical; current review incomplete |
H51-3600AE9A9E96888CEF8B8478 | first-look-v5.1.json/records/229/mechanism_level | Historical; current review incomplete |
H51-F3FAD83AB1F1C6DF201B2331 | first-look-v5.1.json/records/229/basic_dosing_orientation | Historical; current review incomplete |
H51-362922D67BD8EBF9449DEEFF | first-look-v5.1.json/records/229/administration_orientation | Historical; current review incomplete |
H51-8E22BD7C48D91CFA84674486 | first-look-v5.1.json/records/229/renal_and_population_orientation | Historical; current review incomplete |
H51-462BEE5D2CFD98E337FC0AD2 | first-look-v5.1.json/records/229/key_safety_orientation/0 | Historical; current review incomplete |
H51-4DA44EAE6AB9CDB7FD4C084B | first-look-v5.1.json/records/229/key_safety_orientation/1 | Historical; current review incomplete |
H51-C4AA8EB9AF195CD501092906 | first-look-v5.1.json/records/229/coverage_path | Historical; current review incomplete |
H51-C219785D9DDF7AD0B9317523 | first-look-v5.1.json/records/229/coverage_path_label | Historical; current review incomplete |
H51-DF804C734E572E78167484CB | first-look-v5.1.json/records/229/official_label_url | Historical; current review incomplete |
H51-1E74BB2E9D17196CC1876D65 | first-look-v5.1.json/records/229/legacy_title | Historical; current review incomplete |
H51-0DFC48E113875F88EB9CD9A4 | first-look-v5.1.json/records/229/review_note | Historical; current review incomplete |
H51-0E20BF5CF3A31B169E2E70CA | first-look-v5.1.json/records/229/search_text | Historical; current review incomplete |
H51-3108753BECC6E2B61F2A9AEB | first-look-v5.1.json/records/229/official_search_url | Historical; current review incomplete |
H51-2A5EFE43D3A395161E628786 | first-look-v5.1.json/records/229/official_access_mode | Historical; current review incomplete |
H51-73A3C7ED64A8AE43EC9943F0 | first-look-v5.1.json/records/229/official_access_url | Historical; current review incomplete |
H51-433B029A0BB7FF0120416011 | first-look-v5.1.json/records/229/official_search_query | Historical; current review incomplete |
H51-848D53F95B02A4A233C8C66E | first-look-v5.1.json/records/229/official_access_reason | Historical; current review incomplete |
H51-B1E4C27F134629F7FA1C00FC | preparation-assessments-v3.8.json/229/id | Historical; current review incomplete |
H51-ECD9A6739370240CA3F5EF1C | preparation-assessments-v3.8.json/229/name | Historical; current review incomplete |
H51-467C59E1DF24E66AD99CC8E1 | preparation-assessments-v3.8.json/229/brands | Historical; current review incomplete |
H51-2F3A34CB96BF5913422D49EC | preparation-assessments-v3.8.json/229/therapeutic_class | Historical; current review incomplete |
H51-52E58CF2CACD3A6A17BDE8A9 | preparation-assessments-v3.8.json/229/review_version | Historical; current review incomplete |
H51-032FBE276B273B095AE29E10 | preparation-assessments-v3.8.json/229/review_date | Historical; current review incomplete |
H51-F4C362B022243EAF2FEEF47B | preparation-assessments-v3.8.json/229/release_status | Historical; current review incomplete |
H51-F7BB44B88067427D47215C4D | preparation-assessments-v3.8.json/229/market_status/status | Historical; current review incomplete |
H51-82231CC936CD0ED48F432F2C | preparation-assessments-v3.8.json/229/market_status/basis | Historical; current review incomplete |
H51-9740FBA7327AFA8573EF28C0 | preparation-assessments-v3.8.json/229/ten_point_assessment/exact_formulation | Historical; current review incomplete |
H51-572CEFE42BBE2ED45D0E2771 | preparation-assessments-v3.8.json/229/ten_point_assessment/reconstitution_concentration | Historical; current review incomplete |
H51-9A4DF6830FE6C895D6423BD2 | preparation-assessments-v3.8.json/229/ten_point_assessment/maximum_or_recommended_final_concentration | Historical; current review incomplete |
H51-B6927CAE342DB28E8C9EDEF1 | preparation-assessments-v3.8.json/229/ten_point_assessment/appropriate_standardized_containers | Historical; current review incomplete |
H51-43733D7C87DDC0A733DE8A6E | preparation-assessments-v3.8.json/229/ten_point_assessment/adult_dosing_range | Historical; current review incomplete |
H51-A388FEBD7961DB6A8548ED14 | preparation-assessments-v3.8.json/229/ten_point_assessment/pediatric_dosing_range | Historical; current review incomplete |
H51-1BB6518ADDD43BA3667476D2 | preparation-assessments-v3.8.json/229/ten_point_assessment/neonatal_dosing_range | Historical; current review incomplete |
H51-7835278149407E1F333852D0 | preparation-assessments-v3.8.json/229/ten_point_assessment/infusion_time | Historical; current review incomplete |
H51-04A5A0274690D51633C29CEA | preparation-assessments-v3.8.json/229/ten_point_assessment/fluid_restriction_alternatives | Historical; current review incomplete |
H51-D9CAA893FE18305B72331962 | preparation-assessments-v3.8.json/229/ten_point_assessment/current_manufacturer_labeling/setid | Historical; current review incomplete |
H51-595507FAFA1D6F35D68B22D7 | preparation-assessments-v3.8.json/229/ten_point_assessment/current_manufacturer_labeling/title | Historical; current review incomplete |
H51-B6E15994052BF6E517E3832C | preparation-assessments-v3.8.json/229/ten_point_assessment/current_manufacturer_labeling/published_date | Historical; current review incomplete |
H51-A7CCAD42B7F4507B1D09C7D5 | preparation-assessments-v3.8.json/229/ten_point_assessment/current_manufacturer_labeling/manufacturer | Historical; current review incomplete |
H51-EEB6D628BA108ADA8C16F9B4 | preparation-assessments-v3.8.json/229/ten_point_assessment/current_manufacturer_labeling/match_confidence | Historical; current review incomplete |
H51-E481D26C9757E667F99462CA | preparation-assessments-v3.8.json/229/ten_point_assessment/current_manufacturer_labeling/url | Historical; current review incomplete |
H51-0467354849B60423FE22A643 | preparation-assessments-v3.8.json/229/field_provenance/exact_formulation/primary | Historical; current review incomplete |
H51-D1FCD47837D95EA4E2AF0ED3 | preparation-assessments-v3.8.json/229/field_provenance/reconstitution_concentration/primary | Historical; current review incomplete |
H51-CF617E16BD5057F85A0ADACB | preparation-assessments-v3.8.json/229/field_provenance/maximum_or_recommended_final_concentration/primary | Historical; current review incomplete |
H51-E2429A58A3A419CAEA24605E | preparation-assessments-v3.8.json/229/field_provenance/appropriate_standardized_containers/primary | Historical; current review incomplete |
H51-13C611749632580181C97976 | preparation-assessments-v3.8.json/229/field_provenance/adult_dosing_range/primary | Historical; current review incomplete |
H51-921382B6A1BA5A493F6006FE | preparation-assessments-v3.8.json/229/field_provenance/pediatric_dosing_range/primary | Historical; current review incomplete |
H51-C23ACC135B9A8A4DCD8C49C9 | preparation-assessments-v3.8.json/229/field_provenance/neonatal_dosing_range/primary | Historical; current review incomplete |
H51-18EEC1C30D3B54FE7AE2F509 | preparation-assessments-v3.8.json/229/field_provenance/infusion_time/primary | Historical; current review incomplete |
H51-AB8315F54E5080B541D7D0EB | preparation-assessments-v3.8.json/229/field_provenance/fluid_restriction_alternatives/primary | Historical; current review incomplete |
H51-CAF04BD58C4FB3B783100251 | preparation-assessments-v3.8.json/229/field_provenance/current_manufacturer_labeling/primary | Historical; current review incomplete |
H51-5DE97A9A5512044BAE8437EC | preparation-assessments-v3.8.json/229/population_applicability/adult/applicability | Historical; current review incomplete |
H51-BC6A3E4212852815A74AABCD | preparation-assessments-v3.8.json/229/population_applicability/adult/guide_generation_allowed | Historical; current review incomplete |
H51-2B35B2F59BDBAB9540B79B71 | preparation-assessments-v3.8.json/229/population_applicability/pediatric/applicability | Historical; current review incomplete |
H51-AEABE439FB9CD32BF24ADF48 | preparation-assessments-v3.8.json/229/population_applicability/pediatric/guide_generation_allowed | Historical; current review incomplete |
H51-6D041A4E382C548781397EC5 | preparation-assessments-v3.8.json/229/population_applicability/neonatal/applicability | Historical; current review incomplete |
H51-9D3FDD729D5D7C1D224390FD | preparation-assessments-v3.8.json/229/population_applicability/neonatal/guide_generation_allowed | Historical; current review incomplete |
H51-AF07066C27E0EF79CC6A3525 | preparation-assessments-v3.8.json/229/route_presence/structured_dilution | Historical; current review incomplete |
H51-8D4C34DD99D3A66BF240D0BC | preparation-assessments-v3.8.json/229/route_presence/iv_push | Historical; current review incomplete |
H51-5EA23FE528D5AF5B6D15A49B | preparation-assessments-v3.8.json/229/route_presence/continuous_infusion | Historical; current review incomplete |
H51-643684123F8C9024F7741723 | preparation-assessments-v3.8.json/229/route_presence/pediatric_source | Historical; current review incomplete |
H51-17A25F3192F8FD56D7AF0B15 | preparation-assessments-v3.8.json/229/route_presence/neonatal_source | Historical; current review incomplete |
H51-94E2A3AA47AD7B5812510D42 | preparation-assessments-v3.8.json/229/legacy_reference/status | Historical; current review incomplete |
H51-58A0CC2A97723A766BE97A00 | preparation-assessments-v3.8.json/229/label_resolution/status | Historical; current review incomplete |
H51-E54626B50C38A1CA6DA93875 | preparation-assessments-v3.8.json/229/source_files/0 | Historical; current review incomplete |
H51-6C123085903FB2B947703968 | preparation-assessments-v3.8.json/229/source_files/1 | Historical; current review incomplete |
H51-4C229D4A6373A47C7718B655 | preparation-assessments-v3.8.json/229/source_files/2 | Historical; current review incomplete |
H51-247BDE6B123A2F0A32C6BA93 | preparation-assessments-v3.8.json/229/source_files/3 | Historical; current review incomplete |
H51-4B500F463403487A63D8E614 | preparation-assessments-v3.8.json/229/clinical_release_note | Historical; current review incomplete |
Open the original GlobalRPh site monograph (historical; not revalidated) (opens in a new tab)